CYBRD1
Basic information
Region (hg38): 2:171522247-171558129
Links
Phenotypes
GenCC
Source:
- hereditary hemochromatosis (Strong), mode of inheritance: AR
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CYBRD1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 15 | 19 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 15 | 3 | 1 |
Variants in CYBRD1
This is a list of pathogenic ClinVar variants found in the CYBRD1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-171522561-T-C | not specified | Uncertain significance (Jun 30, 2022) | ||
2-171522589-C-T | CYBRD1-related disorder | Likely benign (Feb 03, 2022) | ||
2-171522648-C-G | not specified | Uncertain significance (Oct 26, 2021) | ||
2-171522718-T-G | not specified | Uncertain significance (Apr 12, 2023) | ||
2-171522720-G-A | not specified | Uncertain significance (Apr 22, 2022) | ||
2-171522723-T-C | not specified | Uncertain significance (Jan 18, 2023) | ||
2-171541669-C-T | not specified | Uncertain significance (Dec 17, 2023) | ||
2-171541677-C-T | not specified | Uncertain significance (Sep 14, 2022) | ||
2-171541683-A-G | not specified | Uncertain significance (Dec 21, 2023) | ||
2-171541734-A-G | not specified | Uncertain significance (Jun 21, 2022) | ||
2-171541759-T-C | not specified | Uncertain significance (Mar 29, 2023) | ||
2-171553387-G-A | not specified | Likely benign (Mar 07, 2024) | ||
2-171553470-T-C | not specified | Uncertain significance (Jul 09, 2021) | ||
2-171553471-G-A | not specified | Uncertain significance (May 16, 2023) | ||
2-171554550-C-T | not specified | Uncertain significance (Dec 07, 2023) | ||
2-171554604-C-A | not specified | Uncertain significance (Sep 27, 2021) | ||
2-171554632-G-A | not specified | Likely benign (Nov 28, 2023) | ||
2-171554763-G-A | Benign (Sep 04, 2018) | |||
2-171554814-G-A | not specified | Uncertain significance (Dec 30, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CYBRD1 | protein_coding | protein_coding | ENST00000321348 | 4 | 35887 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0116 | 0.954 | 125717 | 0 | 15 | 125732 | 0.0000597 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.589 | 139 | 160 | 0.869 | 0.00000787 | 1838 |
Missense in Polyphen | 37 | 54.41 | 0.68002 | 635 | ||
Synonymous | -0.924 | 75 | 65.5 | 1.15 | 0.00000357 | 597 |
Loss of Function | 1.83 | 5 | 11.8 | 0.424 | 5.92e-7 | 122 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000231 | 0.000231 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000441 | 0.0000440 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Ferric-chelate reductase that reduces Fe(3+) to Fe(2+). Present at the brush border of duodenal enterocytes where it probably reduces dietary Fe(3+) thereby facilitating its transport into the mucosal cells. Uses ascorbate as electron donor. May be involved in extracellular ascorbate recycling in erythrocyte membranes. May also act as a ferrireductase in airway epithelial cells. {ECO:0000269|PubMed:16521311, ECO:0000269|PubMed:16521312, ECO:0000269|PubMed:17068337, ECO:0000269|PubMed:19673882}.;
- Pathway
- Mineral absorption - Homo sapiens (human);Transport of small molecules;Iron uptake and transport
(Consensus)
Recessive Scores
- pRec
- 0.183
Intolerance Scores
- loftool
- 0.317
- rvis_EVS
- 0.68
- rvis_percentile_EVS
- 84.93
Haploinsufficiency Scores
- pHI
- 0.103
- hipred
- N
- hipred_score
- 0.305
- ghis
- 0.389
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.200
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cybrd1
- Phenotype
- homeostasis/metabolism phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); liver/biliary system phenotype;
Gene ontology
- Biological process
- cellular iron ion homeostasis;response to iron ion;oxidation-reduction process
- Cellular component
- lysosomal membrane;plasma membrane;integral component of membrane;brush border membrane;extracellular exosome
- Molecular function
- ferric-chelate reductase activity;protein binding;oxidoreductase activity;oxidoreductase activity, oxidizing metal ions;metal ion binding